Bortezomib, melphalan, and dexamethasone for light-chain amyloidosis - Kastritis, Efstathios; Leleu, Xavier; Arnulf, Bertrand; Zamagni, Elena; Cibeira, María Teresa; Kwok, Fiona; Mollee, Peter; Hájek, Roman; Moreau, Philippe; Jaccard, Arnaud; Schönland, Stefan; Filshie, Robin; et al. (Journal of clinical oncology, 2020)
Gesehen am 19.04.2021